| scholarly article | Q13442814 |
| P50 | author | Max Bachmann | Q61977216 |
| P2093 | author name string | Jeremy Turner | |
| Allan Clark | |||
| Amanda Howe | |||
| Gerry Rayman | |||
| Mike Sampson | |||
| W Garry John | |||
| Melanie Pascale | |||
| Tim Elwell-Sutton | |||
| Ketan K Dhatariya | |||
| Leyla Swafe | |||
| Clare Ferns | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions | Q30239830 | ||
| Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. | Q51367598 | ||
| HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. | Q51371579 | ||
| Development of diabetes in Japanese subjects with impaired glucose tolerance: a seven year follow-up study. | Q51651719 | ||
| Time to question the NHS diabetes prevention programme | Q57270343 | ||
| Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to p | Q59861915 | ||
| Pavel's "dynamic screening" for diabetes type 2: 14 years results in a district of northern Italy | Q70097523 | ||
| Biological variation of hemoglobin A1c: consequences for diagnosing diabetes mellitus | Q85364467 | ||
| Radically upgrading diabetes prevention in England | Q86971868 | ||
| NHS England rolls out world's first national diabetes prevention programme | Q89046186 | ||
| Beat diabetes: an urgent call for global action | Q89299648 | ||
| The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. | Q30353301 | ||
| Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis | Q30829257 | ||
| Multicentre evaluation of the Premier Hb9210 HbA1c analyser | Q33925054 | ||
| Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor | Q34252924 | ||
| Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies | Q34718461 | ||
| Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis | Q36086147 | ||
| The epidemic of pre-diabetes: the medicine and the politics | Q36449393 | ||
| Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study. | Q37026196 | ||
| Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics. | Q37098167 | ||
| In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. | Q37142827 | ||
| Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one? | Q37331128 | ||
| Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants | Q37368135 | ||
| Nonpharmacological interventions for the prevention of type 2 diabetes mellitus | Q37976306 | ||
| Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis | Q38197970 | ||
| A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program | Q38788567 | ||
| Persistent fasting hyperglycaemia is more predictive of type 2 diabetes than transient fasting hyperglycaemia | Q39677898 | ||
| Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. | Q40248226 | ||
| Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. | Q40288564 | ||
| Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission | Q40809258 | ||
| Determinants of HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and their interactions in the Lifelines Cohort Study | Q44279645 | ||
| Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis | Q46545188 | ||
| The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study | Q46576373 | ||
| Research digest: weight loss to prevent and treat diabetes | Q47271811 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 6240 | |
| P577 | publication date | 2018-04-19 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial | |
| P478 | volume | 8 |
Search more.